The institution-specific uptake of VATS for lung cancer resection in the US Veterans Affairs system was evaluated over the past 15 years. Uptake more than tripled during the study period, with a current mean of more than 50% among institutions. However, uptake ranged from 0 to 82% and was associated with increasing center volume.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung Cancer - Surgery
March 4, 2019
The complete pathologic response rate in this study is revealed to be low, lower than expected after stereotactic ablative radiotherapy (SABR) for early stage non-small cell lung cancer: only 60%. The authors suggest a combined approach (SABR plus surgery), adopted in this experimental phase 2 trial, as a possible management scheme.
January 21, 2019
The authors present a uniportal VATS anatomic right basal segmentectomy performed for the treatment of a 2.5 cm diffuse ground glass opacity adenocarcinoma in the right basal segments, which was found during chronic asthma follow-up.
January 18, 2019
Patient Care and General Interest
Air pollution tops the World Health Organization’s list of Top 10 threats to global health.
January 9, 2019
Cao and colleagues compared outcomes with stereotactic body radiation therapy (SBRT) to surgery for patients with non–small cell lung cancer using a meta-analysis of 23 studies.
December 10, 2018
This video demonstrates how imaging-assisted surgery can enhance the prospects of robotic pulmonary segmentectomy.
October 23, 2018
In a single institution review comparing acute outcomes for men and women after surgery for non-small cell lung cancer, men were found to have an increased risk of postoperative cardiac complications, whereas women were found to have an increased incidence of 30-day readmission, the latter despite similar frequency of postoperative emergency departme
October 23, 2018
Forty-nine patients with limited metastatic non-small cell lung cancer (three or fewer metastatic sites) who did not progress on initial systemic therapy were randomized to surgery or RT vs standard maintenance therapy. Overall survival for the intervention group was 41.2 mos vs 17.0 mos in those getting maintenance therapy (p=0.017).
October 16, 2018
Click on the link below and register for free to gain access to two operations that were performed live in Bologna, Italy, on October 1st, 2018.
https://www.microlobectomy.live/
September 26, 2018
Using the National Cancer Database, the effect of the timing of computed tomography (CT) surveillance after resection of non-small cell lung cancer on survival was investigated. Survival was similar for patients undergoing CTs every three months or every six months compared to those undergoing annual surveillance CTs. More frequent imaging also had